CharlesJParkerMD

Oncology • Salt Lake City, UT

Hematologic Oncology

Professor, Internal Medicine, University of Utah School of Medicine

Join to view full profile

Dr. Parker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Parker's full profile

Already have an account?

Office
1950 Circle of Hope Dr
Salt Lake City, UT 84112
Phone+1 801-581-2121

Fax+1 801-585-3854

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 1978 - 1981
University of North Carolina HospitalsResidency, Internal Medicine, 1975 - 1977
University of North Carolina at Chapel Hill School of MedicineClass of 1975

Certifications & Licensure

UT State Medical License 1985 - 2026
NC State Medical License 1975 - 2002

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1991

Publications & Presentations

PubMed

107 citations
The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C.
Ralph E. Whatley, P. Nelson, Guy A. Zimmerman, D. L. Stevens, Charles J. Parker
The Journal of Biological Chemistry. 1989-04-15
221 citations
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibod...
G D Ross, William J. Yount, Mark Walport, J B Winfield, Charles J. Parker
Journal of Immunology. 1985-09-01
17 citations
Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement.
Charles J. Parker
Clinical and Experimental Immunology. 2008-06-28

Lectures

Evaluation and Treatment of Complement-Mediated Blood Disorders in Women of Childbearing Age
60th American Society of Hematology Annual Meeting - 11/30/2018

Press Mentions

July Research HighlightsAugust 6th, 2023
Multimodal AI Informing Treatment Decisions in Advanced Prostate Cancer - Gerhardt AttardMay 21st, 2024